Search

everythinglearnresearchcommunity

for

Search:↓

Ruxolitinib may help treat hair loss by reducing inflammation, promoting hair growth signals, and protecting hair follicle immunity.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

Skin spheroids with both outer and inner layers are key for regrowing skin patterns and hair.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Alopecia areata severity is linked to increased TH1 and TH2 activity.

New methods to improve the healing abilities of mesenchymal stem cells for disease treatment are promising but need more research.

Trichloroethylene causes skin inflammation in mice by increasing certain immune proteins.

JAK inhibitors helped treat hair loss in two people with Down syndrome.

SOCS3 treatment can prevent hair loss by stopping harmful immune responses.

Hair follicle stem cells reduced hair loss and inflammation in mice with a condition similar to human alopecia.

Promising treatments for EBS include anti-inflammatory drugs, antibiotics, creams, mTOR inhibitors, and gene editing, but more trials are needed.

Retinol may affect immune responses in people with frequent skin boils.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

The IGRA test effectively detects past SARS-CoV-2 exposure, especially using nucleocapsid peptides.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

Plakophilin 1 helps control skin cell immune responses to prevent excessive inflammation.

Inhibiting TYK2 can restore hair growth in alopecia areata.

Understanding molecular mediators can improve skin healing treatments.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

A specific DNA sequence caused hair loss in male mice by activating immune cells and increasing a certain immune signal.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

Sorafenib may cause hair loss in a way similar to alopecia areata.

Some multiple sclerosis treatments may trigger hair loss conditions like alopecia areata.